Real-World Patient Outcomes on the Efficacy of Lanreotide Treatment for Neuroendocrine Tumors: The Influence of Body Mass Index, Body Surface Area, and Renal Function

Ilse de Weert; Mirjam Crul; Heinz-Josef Klümpen; Tim Schutte

doi:10.1159/000548257

Real-World Patient Outcomes on the Efficacy of Lanreotide Treatment for Neuroendocrine Tumors: The Influence of Body Mass Index, Body Surface Area, and Renal Function

Ilse de Weert
, Mirjam Crul
, Heinz-Josef Klümpen
, Tim Schutte

Amsterdam UMC - University of Amsterdam
Netherlands Cancer Institute

Research output: Contribution to journal › Article › Academic › peer-review

33 Downloads (Pure)

Original language	English
Pages (from-to)	1-12
Number of pages	12
Journal	Neuroendocrinology
Early online date	2025
DOIs	https://doi.org/10.1159/000548257
Publication status	E-pub ahead of print - 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Body mass index
Body surface area
Lanreotide
Neuroendocrine cancer
Neuroendocrine neoplasms
Neuroendocrine tumors
Real-world data

Access to Document

10.1159/000548257

Real-world-patient-outcomes-on-the-efficacy-of-lanreotide-treatment-for-neuroendocrine-tumors.pdfFinal published version, 1.92 MBLicence: CC BY

Cite this

@article{5009e30368464ef19d61adc9241adc3c,

title = "Real-World Patient Outcomes on the Efficacy of Lanreotide Treatment for Neuroendocrine Tumors: The Influence of Body Mass Index, Body Surface Area, and Renal Function",

keywords = "Body mass index, Body surface area, Lanreotide, Neuroendocrine cancer, Neuroendocrine neoplasms, Neuroendocrine tumors, Real-world data",

author = "\{de Weert\}, Ilse and Mirjam Crul and Heinz-Josef Kl{\"u}mpen and Tim Schutte",

year = "2025",

doi = "10.1159/000548257",

language = "English",

pages = "1--12",

journal = "Neuroendocrinology",

issn = "0028-3835",

publisher = "S. Karger AG",

}

TY - JOUR

T1 - Real-World Patient Outcomes on the Efficacy of Lanreotide Treatment for Neuroendocrine Tumors

T2 - The Influence of Body Mass Index, Body Surface Area, and Renal Function

AU - de Weert, Ilse

AU - Crul, Mirjam

AU - Klümpen, Heinz-Josef

AU - Schutte, Tim

PY - 2025

Y1 - 2025

KW - Body mass index

KW - Body surface area

KW - Lanreotide

KW - Neuroendocrine cancer

KW - Neuroendocrine neoplasms

KW - Neuroendocrine tumors

KW - Real-world data

UR - https://www.scopus.com/pages/publications/105018714584

U2 - 10.1159/000548257

DO - 10.1159/000548257

M3 - Article

C2 - 40892702

SN - 0028-3835

SP - 1

EP - 12

JO - Neuroendocrinology

JF - Neuroendocrinology

ER -

Real-World Patient Outcomes on the Efficacy of Lanreotide Treatment for Neuroendocrine Tumors: The Influence of Body Mass Index, Body Surface Area, and Renal Function

UN SDGs

Keywords

Access to Document

Other files and links

Cite this